Plasma homovanillic acid in schizotypal personality disorder

  • Larry J. Siever
  • , Farooq Amin
  • , Emil F. Coccaro
  • , David Bernstein
  • , Richard J. Kavoussi
  • , Oren Kalus
  • , Thomas B. Horvath
  • , Patricia Warne
  • , Michael Davidson
  • , Kenneth L. Davis

Research output: Contribution to journalArticlepeer-review

Abstract

Schizotypal patients were found to have a significantly higher mean plasma HVA concentration than normal comparison subjects, Furthermore, plasma HVA concentration positively correlated with "psychotic-like" schizotypal symptoms. These results implicate dopaminergic mechanisms modulating the psychotic-like symptoms of schizotypal personality disorder.

Original languageEnglish
Pages (from-to)1246-1248
Number of pages3
JournalAmerican Journal of Psychiatry
Volume148
Issue number9
Publication statusPublished - 1991

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Plasma homovanillic acid in schizotypal personality disorder'. Together they form a unique fingerprint.

Cite this